Provided by Tiger Trade Technology Pte. Ltd.

DNA X

3.23
-0.2100-6.10%
Post-market: 3.230.00000.00%16:10 EDT
Volume:14.86K
Turnover:48.91K
Market Cap:4.81M
PE:-0.21
High:3.36
Open:3.33
Low:3.20
Close:3.44
52wk High:16.97
52wk Low:2.52
Shares:1.49M
Float Shares:1.18M
Volume Ratio:2.04
T/O Rate:1.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-15.4252
EPS(LYR):-28.5835
ROE:-455.82%
ROA:-8.31%
PB:-3.90
PE(LYR):-0.11

Loading ...

DNA X Q2 EPS $(0.91) Up From $(14.15) YoY

Benzinga Earnings
·
Aug 20

DNA X Q2 FY26 Net Loss from Continuing Operations Narrows to USD 1.24 Million; Revenue Holds at no Revenue

Reuters
·
Aug 20

DNA X Inc: Expects Revenue from Trading Platform to Begin Towards End of Q3 2026 or Beginning of Q4 2026

THOMSON REUTERS
·
Aug 20

DNA X, Inc. Reports Second Quarter 2026 Financial Results

GlobeNewswire
·
Aug 20

DNA X Delays Q2 10-Q Filing, Cites Convertible Debt and Consolidation Accounting Complexities

Reuters
·
Aug 15

DNA X Amends 8-K to Update Disclosure on Series B Preferred Stock Sale for $2.5 Million

Reuters
·
Aug 14

DNA X Amends 8-K to Update Disclosure on Series B Preferred Stock Sale and Note Conversion

Reuters
·
Jul 10

DNA X - to Issue 1.35 Mln Series B Preferred Shares at $6 Each for $8.1 Mln - SEC Filing

THOMSON REUTERS
·
Jul 02

DNA X - Enters Securities Purchase Agreement with DNA Holdings on June 29, 2026 - SEC Filing

THOMSON REUTERS
·
Jul 02

DNA X Announces Private Placement of 1,346,531 Series B Preferred Shares for USD 8.1 Million

Reuters
·
Jul 02

DNA X enters USD 3.05 million convertible note financing with DNA Holdings Venture

Reuters
·
May 28

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:55 AM

Reuters
·
May 22

DNA X Inc Says No Revenue From Continuing Operations for Q1 Because Revenue From Phone and Hotspot Operations Included in Discontinued Operations

THOMSON REUTERS
·
May 21

DNA X Inc - Q1 Loss per Share From Cont. Opns. $3.11

THOMSON REUTERS
·
May 21

Sonim Technologies Q1 EPS $5.01 Misses $5.04 Estimate

Benzinga Earnings
·
May 21

DNA X Q1 FY26 swings to net income of $6.34 million

Reuters
·
May 21

DNA X, Inc. Delays Quarterly Filing After Asset Sale

TIPRANKS
·
May 16

DNA X delays Q1 10-Q filing after legacy business sale accounting complexity

Reuters
·
May 16

DNA X dismisses Baker Tilly, appoints TAAD as new auditor

Reuters
·
May 01

DNA X FY25 net loss widens to $20.7 million; operating loss grows to $5.4 million

Reuters
·
Apr 15